These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Variable designs of clinical trials of neuromuscular blocking agents: an example of studies comparing rocuronium and vecuronium. Nava-Ocampo AA; Velázquez-Armenta Y; Moyao-García D; Antonio-Ocampo A; Salmerón J Med Sci Monit; 2005 Feb; 11(2):PI22-30. PubMed ID: 15668623 [TBL] [Abstract][Full Text] [Related]
24. [The effect of neuromuscular blocking agents on the pre-and postjunctional receptors at the neuromuscular junction]. Amaki Y Masui; 1985 Sep; 34(9):1185-93. PubMed ID: 3003417 [No Abstract] [Full Text] [Related]
25. Monitoring of neuromuscular function. Ali HH Middle East J Anaesthesiol; 1989 Oct; 10(3):261-78. PubMed ID: 2637950 [TBL] [Abstract][Full Text] [Related]
27. Initial studies in man with a new myoneural blocking agent (ORG.6368). Baird WL Br J Anaesth; 1974 Sep; 46(9):658-61. PubMed ID: 4621174 [No Abstract] [Full Text] [Related]
28. [Neuromuscular junction: pharmacology, toxicology and clinical use of neuromuscular blocking agents]. Conte-Camerino D; Siro-Brigiani G Clin Ter; 1975 Mar; 72(5):461-91. PubMed ID: 773593 [No Abstract] [Full Text] [Related]
29. [The importance of neuromuscular monitoring during anesthesia for neuroradiologic diagnosis]. Schönstedt R; Böhrer H Anaesthesiol Reanim; 1993; 18(2):53-6. PubMed ID: 8397672 [TBL] [Abstract][Full Text] [Related]
30. [French survey of neuromuscular relaxant use in anaesthetic practice in adults]. Duvaldestin P; Cunin P; Plaud B; Maison P Ann Fr Anesth Reanim; 2008 Jun; 27(6):483-9. PubMed ID: 18571891 [TBL] [Abstract][Full Text] [Related]
31. [The effects of atracurium on neuromuscular transmission in rats]. Otagiri T Masui; 1984 Oct; 33(10):1122-9. PubMed ID: 6097700 [No Abstract] [Full Text] [Related]
32. [Blocking effects of cycleanine dimethobromide on nerve ganglia and neuromuscular junctions (author's transl)]. Lu YQ; Xu DZ; Mao YK; Wei X; Yang ZC Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):223-6. PubMed ID: 6462019 [No Abstract] [Full Text] [Related]
35. Pre- and postjunctional effects of neuromuscular blocking agents and their antagonists. Jones RM; Williams JP; Pearce AC Anesth Analg; 1983 Dec; 62(12):1137-8. PubMed ID: 6650902 [No Abstract] [Full Text] [Related]
36. Neuromuscular pharmacology. A clinical update and commentary. Lee C; Katz RL Br J Anaesth; 1980 Feb; 52(2):173-88. PubMed ID: 6244842 [No Abstract] [Full Text] [Related]
39. The neuromuscular transmission monitor. A clinical assessment and comparison with a force transducer. Windsor JP; Sebel PS; Flynn PJ Anaesthesia; 1985 Feb; 40(2):146-51. PubMed ID: 2983581 [TBL] [Abstract][Full Text] [Related]
40. Differing interactions between hexamethonium and tubocurarine, pancuronium or alcuronium at the neuromuscular junction. Pollard BJ; van der Spek AF Br J Anaesth; 1988 Oct; 61(4):419-24. PubMed ID: 2903757 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]